Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 53 checked references that resolve
resolves10.1002/ajmg.1320600317Clinical, cytogenetic, and molecular diagnosis of Angelman syndrome: Estimated prevalence rate in a Danish county
resolves10.1242/dmm.011007Preclinical research in Rett syndrome: setting the foundation for translational success
resolves10.1016/S0896-6273(00)80596-6Mutation of the Angelman Ubiquitin Ligase in Mice Causes Increased Cytoplasmic p53 and Deficits of Contextual Learning and Long-Term Potentiation
resolves10.1186/1471-2156-12-7Normal social seeking behavior, hypoactivity and reduced exploratory range in a mouse model of Angelman syndrome
resolves10.1371/journal.pone.0012278Altered Ultrasonic Vocalization and Impaired Learning and Memory in Angelman Syndrome Mouse Model with a Large Maternal Deletion from Ube3a to Gabrb3
resolves10.1006/nbdi.2001.0463Neurobehavioral and Electroencephalographic Abnormalities in Ube3aMaternal-Deficient Mice
resolves10.1038/nn1845Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of αCaMKII inhibitory phosphorylation
resolves10.1523/JNEUROSCI.23-07-02634.2003Derangements of Hippocampal Calcium/Calmodulin-Dependent Protein Kinase II in a Mouse Model for Angelman Mental Retardation Syndrome
resolves10.1002/ajmg.a.38457A randomized controlled trial of levodopa in patients with Angelman syndrome
resolves10.1186/s13023-018-0891-6A randomized placebo controlled clinical trial to evaluate the efficacy and safety of minocycline in patients with Angelman syndrome (A-MANECE study)
resolves10.1136/jmg.2008.061796Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model
resolves10.1038/sj.jcbfm.9600268Dose–Response Effect of Tetracyclines on Cerebral Matrix Metalloproteinase-9 after Vascular Endothelial Growth Factor Hyperstimulation
resolves10.1111/j.1460-9568.2005.04182.xMinocycline blocks bilirubin neurotoxicity and prevents hyperbilirubinemia‐induced cerebellar hypoplasia in the Gunn rat
resolves10.1016/j.ejphar.2013.10.063Interactions of levetiracetam with carbamazepine, phenytoin, topiramate and vigabatrin in the mouse 6Hz psychomotor seizure model – A type II isobolographic analysis
resolves10.3758/BF03193146G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
resolves10.3791/50978Marble Burying and Nestlet Shredding as Tests of Repetitive, Compulsive-like Behaviors in Mice
resolves10.1371/journal.pgen.1004039Truncation of Ube3a-ATS Unsilences Paternal Ube3a and Ameliorates Behavioral Defects in the Angelman Syndrome Mouse Model
resolves10.1016/j.brainres.2011.12.041Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome
resolves10.1111/ejn.12893Reelin supplementation recovers synaptic plasticity and cognitive deficits in a mouse model for Angelman syndrome
resolves10.1016/j.nbd.2012.04.002Ampakines promote spine actin polymerization, long-term potentiation, and learning in a mouse model of Angelman syndrome
resolves10.1007/s00018-016-2269-zmTORC1–S6K1 inhibition or mTORC2 activation improves hippocampal synaptic plasticity and learning in Angelman syndrome mice
resolves10.1038/srep02116Location- and sex-specific differences in weight and motor coordination in two commonly used mouse strains
resolves10.1002/ajmg.a.33179A novel <i>UBE3A</i> truncating mutation in large Tunisian Angelman syndrome pedigree
resolves10.1038/nmeth.1312Environmental standardization: cure or cause of poor reproducibility in animal experiments?
The 5 references without a DOI — listed, not checked
no DOI — not checkedSilva-santos S, Van Woerden GM, Bruinsma CF, Mientjes E, Jolfaei MA, Distel B, et al. Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model. J Clin Invest. 2015;125Silva-s:1–8.
no DOI — not checkedWang T, van Woerden GM, Elgersma Y, Borst JGG. Enhanced transmission at the calyx of Held synapse in a mouse model for Angelman syndrome. Front Cell Neurosci. 2018;11:1–19.
no DOI — not checkedGrieco J. Minocycline treatment and the necessity to develop a novel outcome measure for children with Angelman syndrome. Grad Theses Diss. 2015; http://scholarcommons.usf.edu/etd/5693 .
no DOI — not checkedVan Zutphen LFM, Baumans V, Beynen AC. Principles of laboratory animal science: a contribution to the humane use and care of animals and to the quality of experimental results. Amsterdam: Elsevier B.V.; 2001.
no DOI — not checkedPelc K, Cheron G, Dan B. Behavior and neuropsychiatric manifestations in Angelman syndrome. Neuropsychiatric Dis Treat. 2008;4(3):577–84.
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.